Cargando…
Effectiveness of Long-acting Trimetazidine in Different Clinical Situations in Patients with Stable Angina Pectoris: Findings from ODA Trial
INTRODUCTION: Trimetazidine (TMZ) has been shown to be efficacious for angina treatment. The TMZ 80-mg formulation allows one-daily (od) dosage, which could improve symptom control and adherence. METHODS: The 3-month, observational, multicenter, prospective ODA (antianginal effectiveness and tolerab...
Autores principales: | Glezer, Maria G., Vygodin, Vladimir A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525211/ https://www.ncbi.nlm.nih.gov/pubmed/30778909 http://dx.doi.org/10.1007/s40119-019-0128-3 |
Ejemplares similares
-
Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA
por: Glezer, Maria G., et al.
Publicado: (2020) -
Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice
por: Glezer, Maria G., et al.
Publicado: (2018) -
Trimetazidine Improves the Outcome of EECP Therapy in Patients with Refractory Angina Pectoris
por: Shaker, Saad Rasool, et al.
Publicado: (2020) -
Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris
por: Pozdnyakov, Yuri M.
Publicado: (2018) -
Trimetazidine and Bisoprolol to Treat Angina in Symptomatic Patients: Post Hoc Analysis From the CHOICE-2 Study
por: Glezer, Maria
Publicado: (2020)